Have a Claim?

Click here for a confidential contact or call:

1-212-350-2774

Whistleblower News From The Inside — July 15, 2015

Posted  July 15, 2015

By the C|C Whistleblower Lawyer Team

Whistleblower’s phone call halts child-endangerment on set of Divergent movie sequel.  After a whistleblower’s frantic calls, union representatives stepped in to halt the shooting of chaotic scenes with child actors, some as young as four, scrambling through a gauntlet of 100+ untrained adult extras swinging metal clubs, axes and machetes.  Deadline.

Nine defendants charged in scam involving complex, international stock manipulation and money laundering.  A newly unsealed indictment alleges a “pump and dump” manipulation scheme facilitated by an offshore brokerage and money laundering platform controlled by one of the defendants, Harold Bailey Gallison II, to create nominee accounts in shell companies to hide ownership of assets.  DOJ.

Mortgage company owner, co-developer and underwriter plead guilty to $64 million mortgage fraud scheme.  Loans insured by FHA’s HUD division were procured by falsified documents in loan applications.  DOJ.

VA drops criminal probe against hospital whistleblower.  A Veteran’s Affairs hospital medical worker who blew the whistle with a secret appointment list revealing that numerous vets languished while awaiting care is no longer the subject of a criminal investigation, but still has not been restored to his prior position.  Fox.

FDA bans imports from India plant of Emcure Pharmaceuticals.  “In an ‘import alert’ posted on its website on Monday, the FDA said it had barred imports from Emcure’s Hinjewadi manufacturing plant in the western state of Maharashtra, after an inspection revealed the company was not meeting manufacturing quality standards.”  Economic Times.

Waiting for the other shoe to drop at Insys.   Hints at broader federal investigation after top-prescribing advanced care nurse pleads guilty to taking kickbacks for prescribing market-dominant Subsys, a potent opioid approved for breakthrough cancer pain but reportedly provided to beneficiaries who did not have cancer.  SIRF.